Actively Recruiting
Development and Standardization of a New Memory Test for Diagnosing Alzheimers Disease in Adults Aged 50 and Older
Led by University Hospital, Tours · Updated on 2026-04-30
150
Participants Needed
1
Research Sites
N/A
Total Duration
AI-Summary
What This Trial Is About
Episodic memory is an important marker for Alzheimers disease, but current tests often overlook the emotional and identity-related aspects of memory. Researchers have developed a new tool called the New evaluation of Episodic Memory NEM that integrates these factors. The goal is to assess how well this tool helps in diagnosing Alzheimers disease compared to existing methods. Participants will undergo the new memory assessment as part of their routine neuropsychological evaluation. This involves completing traditional neuropsychological tests designed to explore memory function, with a focus on the emotional and contextual aspects of memories. The study group consists of patients who receive this new assessment during their clinical care. Throughout the study, researchers will measure the total score on the NEM tool and examine detailed sub-scores, along with traditional memory recall tests. These assessments will take place at baseline to evaluate the tools effectiveness. The study is observational, and participants will be monitored without receiving experimental treatments. The research is planned to continue until November 2028, with involvement starting from November 2024.
CONDITIONS
Brief Title
Development, Standardisation and Standardisation Project for a New Memory Assessment
Research Team
A
Alix LAUNAY
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here